There are multiple potential applications for circulating tumor (ct)DNA in kidney cancer. The post-nephrectomy remission, adjuvant therapy decision, and monitoring for response or progression on ...
Source: Getty Images KIM-1 may provide prognostic value in RCC, according to Laurence Albiges, MD, PhD. Patients with high KIM-1 levels had significantly worse disease-free survival than patients with ...
In landmark analyses, patients with recurrence by each landmark point had shorter subsequent OS compared with those who did not have recurrence. Longer disease-free survival (DFS) following initial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback